179 related articles for article (PubMed ID: 17015716)
1. Absence of innate MyD88 signaling promotes inducible allograft acceptance.
Walker WE; Nasr IW; Camirand G; Tesar BM; Booth CJ; Goldstein DR
J Immunol; 2006 Oct; 177(8):5307-16. PubMed ID: 17015716
[TBL] [Abstract][Full Text] [Related]
2. Absence of MyD88 signaling induces donor-specific kidney allograft tolerance.
Wu H; Noordmans GA; O'Brien MR; Ma J; Zhao CY; Zhang GY; Kwan TK; Alexander SI; Chadban SJ
J Am Soc Nephrol; 2012 Oct; 23(10):1701-16. PubMed ID: 22878960
[TBL] [Abstract][Full Text] [Related]
3. Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.
Li C; Zhang LM; Zhang X; Huang X; Liu Y; Li MQ; Xing S; Yang T; Xie L; Jiang FC; Jiang HY; He WT; Zhou P
Transplantation; 2017 Feb; 101(2):284-293. PubMed ID: 27607533
[TBL] [Abstract][Full Text] [Related]
4. Type 1 IFN mediates cross-talk between innate and adaptive immunity that abrogates transplantation tolerance.
Thornley TB; Phillips NE; Beaudette-Zlatanova BC; Markees TG; Bahl K; Brehm MA; Shultz LD; Kurt-Jones EA; Mordes JP; Welsh RM; Rossini AA; Greiner DL
J Immunol; 2007 Nov; 179(10):6620-9. PubMed ID: 17982052
[TBL] [Abstract][Full Text] [Related]
5. A tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by activation of antigen-specific CD4+CD25+ T regulatory cells that promotes skin allograft survival in mice.
Fu BM; He XS; Yu S; Hu AB; Zhang J; Ma Y; Tam NL; Huang JF
Cell Immunol; 2010; 261(1):69-76. PubMed ID: 20038461
[TBL] [Abstract][Full Text] [Related]
6. Myeloid differentiation factor 88-silenced bone marrow-derived dendritic cells exhibit enhanced tolerogenicity in intestinal transplantation in rats.
Zhu C; Xu H; Zhang G; Lu C; Ji M; Wu W
Transplant Proc; 2008 Jun; 40(5):1625-8. PubMed ID: 18589162
[TBL] [Abstract][Full Text] [Related]
7. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection.
Goldstein DR; Tesar BM; Akira S; Lakkis FG
J Clin Invest; 2003 May; 111(10):1571-8. PubMed ID: 12750407
[TBL] [Abstract][Full Text] [Related]
8. Short-term MyD88 inhibition ameliorates cardiac graft rejection and promotes donor-specific hyporesponsiveness of skin grafts in mice.
He WT; Zhang LM; Li C; Li SY; Ding ZC; Fang ZM; Meng FY; Chen ZK; Zhou P
Transpl Int; 2016 Aug; 29(8):941-52. PubMed ID: 27125343
[TBL] [Abstract][Full Text] [Related]
9. Myd88 Initiates Early Innate Immune Responses and Promotes CD4 T Cells during Coronavirus Encephalomyelitis.
Butchi N; Kapil P; Puntambekar S; Stohlman SA; Hinton DR; Bergmann CC
J Virol; 2015 Sep; 89(18):9299-312. PubMed ID: 26136579
[TBL] [Abstract][Full Text] [Related]
10. Haptoglobin activates innate immunity to enhance acute transplant rejection in mice.
Shen H; Song Y; Colangelo CM; Wu T; Bruce C; Scabia G; Galan A; Maffei M; Goldstein DR
J Clin Invest; 2012 Jan; 122(1):383-7. PubMed ID: 22156194
[TBL] [Abstract][Full Text] [Related]
11. Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation.
Goldstein DR; Palmer SM
J Heart Lung Transplant; 2005 Nov; 24(11):1721-9. PubMed ID: 16297771
[TBL] [Abstract][Full Text] [Related]
12. MyD88-dependent signaling drives host survival and early cytokine production during Histoplasma capsulatum infection.
Coady A; Sil A
Infect Immun; 2015 Apr; 83(4):1265-75. PubMed ID: 25583527
[TBL] [Abstract][Full Text] [Related]
13. Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs.
Subramanian M; Thorp E; Hansson GK; Tabas I
J Clin Invest; 2013 Jan; 123(1):179-88. PubMed ID: 23257360
[TBL] [Abstract][Full Text] [Related]
14. [Role of innate immunity in tolerance induction].
Dolgikh MS
Biomed Khim; 2015; 61(5):560-78. PubMed ID: 26539864
[TBL] [Abstract][Full Text] [Related]
15. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
Cong L; Wang SF; Zhao ZL; Yang RY
Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
[TBL] [Abstract][Full Text] [Related]
16. Signaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells.
Forward NA; Furlong SJ; Yang Y; Lin TJ; Hoskin DW
J Leukoc Biol; 2010 Jan; 87(1):117-25. PubMed ID: 19843574
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptors and other links between innate and acquired alloimmunity.
Goldstein DR
Curr Opin Immunol; 2004 Oct; 16(5):538-44. PubMed ID: 15341996
[TBL] [Abstract][Full Text] [Related]
18. The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway.
Uto T; Akagi T; Yoshinaga K; Toyama M; Akashi M; Baba M
Biomaterials; 2011 Aug; 32(22):5206-12. PubMed ID: 21492934
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell specific targeting of MyD88 signalling pathways in vivo.
Arnold-Schrauf C; Berod L; Sparwasser T
Eur J Immunol; 2015 Jan; 45(1):32-9. PubMed ID: 25403892
[TBL] [Abstract][Full Text] [Related]
20. [Development of immune tolerance in liver transplantation].
Pons JA; Revilla-Nuin B; Ramírez P; Baroja-Mazo A; Parrilla P
Gastroenterol Hepatol; 2011 Mar; 34(3):155-69. PubMed ID: 21376423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
